GILD
GILEAD SCIENCES
Health Care·Biotechnology·UNITED STATES
$143.44
MCap $177.9B
as of 2026-08-20
Total
C1w
Fund
C9w
Quant
C1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.51
Sentiment 81.7%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$143.44
Adaptive Mean
$145.03
-1.59 vs mean
Adaptive σ
1.55
MIDOS BB
$141.93 – $148.12
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-06
Composite Z
+0.23
ROE
43.4%
Z +0.98
Rev Gr
4.4%
Z -0.26
EPS Gr
54.8%
Z +4.42
OPM Gr
—
Z -0.28
FCF Yld
4.9%
Z +0.43
EPS Surp
0.1%
Z -0.03
EPS 3mo Δ
-460.5%
Z -3.65
Fwd P/E
14.50
Z —
PEGY
0.05
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
6.92
Q6M
-3.81
Q12M
3.59
MA 30/100
1.011
Bullish (MA30 > MA100)
α (Jensen)
0.3667
β (12M)
0.35
σ (12M)
0.267
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
82%
Q Percentile
68%
Divergence
+13.8
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-19.1
RS Pctl
30%
RS Decile
D3
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.